VACCINATION OF CLL PATIENTS WITH AUTOLOGOUS DENDRITIC CELLS LOADED WITH APOPTOTIC BODIES (APO-DC): A PHASE I-II CLINICAL TRIAL

被引：0
|
作者：
Palma, M. [1 ]
Hansson, L. [2 ]
Adamson, L. [1 ]
Eriksson, I. [1 ]
Nasman-Glaser, B. [1 ]
Widen, K. [1 ]
Choudhury, A. R. [1 ]
Osterborg, A. [2 ]
Mellstedt, H. [3 ]
机构：
[1] Karolinska Inst, Canc Ctr Karolinska, Stockholm, Sweden
[2] Karolinska Univ Hosp, Stockholm, Sweden
[3] Karolinska Univ Hosp Solna, Dept Oncol, Stockholm, Sweden
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：164 / 164
页数：1
相关论文
共 50 条
  • [41] Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial
    Kharaziha, Pedram
    Hellstrom, Per M.
    Noorinayer, Babak
    Farzaneh, Farivar
    Aghajani, Katayoun
    Jafari, Fereshteh
    Telkabadi, Mohammad
    Atashi, Amir
    Honardoost, Maryam
    Zali, Mohammad Reza
    Soleimani, Masoud
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (10) : 1199 - 1205
  • [42] Autologous dendritic cells loaded with allogeneic tumor cell lysate in patients with mesothelioma: A phase I study
    Aerts, Joachim G.
    Cornelissen, Robin
    van der Leest, Cor
    Eskens, Ferry
    Bezemer, Koen
    Kaijen, Margaretha
    Hendriks, Rudi
    Hegmans, Joost
    Hoogsteden, Henk C.
    CANCER RESEARCH, 2015, 75
  • [43] Phase I/II trial of immunotherapy with idiotype-loaded autologous dendritic cells (APC8020) for refractory multiple myeloma.
    MacKenzie, M
    Strang, G
    Peshwa, M
    Sopapan, J
    Valone, F
    BLOOD, 1998, 92 (10) : 108A - 108A
  • [44] Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA
    Kyte, J. A.
    Mu, L.
    Aamdal, S.
    Kvalheim, G.
    Dueland, S.
    Hauser, M.
    Gullestad, H. P.
    Ryder, T.
    Lislerud, K.
    Hammerstad, H.
    Gaudernack, G.
    CANCER GENE THERAPY, 2006, 13 (10) : 905 - 918
  • [45] Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial
    Oshita, Chie
    Takikawa, Masako
    Kume, Akiko
    Miyata, Haruo
    Ashizawa, Tadashi
    Iizuka, Akira
    Kiyohara, Yoshio
    Yoshikawa, Shusuke
    Tanosaki, Ryuji
    Yamazaki, Naoya
    Yamamoto, Akifumi
    Takesako, Kazutoh
    Yamaguchi, Ken
    Akiyama, Yasuto
    ONCOLOGY REPORTS, 2012, 28 (04) : 1131 - 1138
  • [46] Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA
    J A Kyte
    L Mu
    S Aamdal
    G Kvalheim
    S Dueland
    M Hauser
    H P Gullestad
    T Ryder
    K Lislerud
    H Hammerstad
    G Gaudernack
    Cancer Gene Therapy, 2006, 13 : 905 - 918
  • [47] A phase I/II clinical trial evaluating RNA-loaded dendritic cells targeting human cytomegalovirus in patients with newly-diagnosed GBM
    Sampson, John H.
    Mitchell, Duane A.
    Archer, Gary E.
    McGehee-Norman, Sharon
    Perry, Beth A.
    Lally-Goss, Denise
    Schinittling, Robert
    Bigner, Darell D.
    Friedman, Allan H.
    Friedman, Henry S.
    Reardon, David A.
    JOURNAL OF NEUROSURGERY, 2008, 108 (04) : A849 - A850
  • [48] Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
    Yamanaka, R
    Abe, T
    Yajima, N
    Tsuchiya, N
    Tsuchiya, N
    Homma, J
    Kobayashi, T
    Narita, M
    Takahashi, M
    Tanaka, R
    BRITISH JOURNAL OF CANCER, 2003, 89 (07) : 1172 - 1179
  • [49] Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
    R Yamanaka
    T Abe
    N Yajima
    N Tsuchiya
    J Homma
    T Kobayashi
    M Narita
    M Takahashi
    R Tanaka
    British Journal of Cancer, 2003, 89 : 1172 - 1179
  • [50] Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: Results of a clinical phase I/II trial
    Yamanaka, R
    Homma, J
    Yajima, N
    Tsuchiya, N
    Tanaka, R
    MOLECULAR THERAPY, 2004, 9 : S98 - S98
12345